1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Summary of anatomic and clinical results
Patient/Age (y)/Sex Location Size (mm) Neck (mm) Ruptured Embolics ACT (seconds) Abciximab Hunt-Hess Grade Angiographic Outcome 1/71/F Anterior communicating artery 5 × 4 3 Yes GDC, Matrix 327 Intra-arterial 5 mg IV Recanalization, contrast-agent extravasation 2/48/M L pericallosal, L parietal arteriovenous malformation 7 × 5 4 No GDC, glue 270 Intra-arterial 2 mg NA Recanalization 3/56/F R middle cerebral artery bifurcation 7 × 6 6 Yes GDC 340 Intra-arterial 5 mg, 17-mg intravenous bolus II Recanalization 4/45/F R superior hypophyseal 7 × 6 4 No DCS, Matrix 231 Intra-arterial 2 mg, 3-mg intravenous bolus NA Recanalization 5/47/M L middle cerebral artery bifurcation 8 × 7 5 No GDC, Microplex 315 Intra-arterial 5 mg NA No recanalization 6/48/F R posterior communicating artery 7 × 7 3 Yes GDC 256 Intra-arterial 5 mg I Partial recanalization 7/50/F Anterior communicating artery 5 × 4 3 Yes GDC 257 Intra-arterial 5 mg I Recanalization, contrast-agent extravasation
Note.—None of the patients had new neurologic deficits after the procedure. NA indicates not applicable.